Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Duopharma Biotech Bhd
KLSE:DPHARMA
Price:
1.1
MYR
Market Closed
Market Cap:
1.1B
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
G
|
Gamuda Bhd
KLSE:GAMUDA
|
MY |
|
A
|
Aubay SA
LSE:0IPY
|
FR |
|
D
|
DPI Holdings Bhd
KLSE:DPIH
|
MY |
|
E
|
EA Holdings Bhd
KLSE:EAH
|
MY |
|
D
|
DKSH Holdings (Malaysia) Bhd
KLSE:DKSH
|
MY |
|
F
|
FM Global Logistics Holdings Bhd
KLSE:FM
|
MY |
|
C
|
CMS Edu Co Ltd
KOSDAQ:225330
|
KR |
|
Foothills Exploration Inc
OTC:FTXP
|
US |
|
D
|
Dagang NeXchange Bhd
KLSE:DNEX
|
MY |
|
G
|
Gdex Bhd
KLSE:GDEX
|
MY |
|
Nichirei Corp
OTC:NCHEF
|
JP |
|
E
|
Eversafe Rubber Bhd
KLSE:ESAFE
|
MY |
|
F
|
Frontken Corporation Bhd
KLSE:FRONTKN
|
MY |
|
E
|
Ep Manufacturing Bhd
KLSE:EPMB
|
MY |
|
E
|
Econframe Bhd
KLSE:EFRAME
|
MY |
|
E
|
Eksons Corporation Bhd
KLSE:EKSONS
|
MY |
|
G
|
Guan Chong Bhd
KLSE:GCB
|
MY |
|
G
|
Green Ocean Corporation Bhd
KLSE:GOCEAN
|
MY |
|
D
|
D'nonce Technology Bhd
KLSE:DNONCE
|
MY |
|
EVI Industries Inc
F:2YE
|
US |
|
D
|
Dps Resources Bhd
KLSE:DPS
|
MY |
|
W
|
Westwater Resources Inc
F:UCCP
|
US |
|
3
|
3D Oil Ltd
F:MUE
|
AU |
Wall St Price Targets
DPHARMA Price Forecast
Based on 7 analysts
Based on 7 analysts
+57% Upside
from
1.1 MYR
today
Duopharma Biotech Bhd (DPHARMA)’s 12-month stock price forecast through October 2027 has a consensus target of 1.72 MYR, implying 57% upside. The forecast is based on price targets from 7 Wall Street analysts.
Duopharma Biotech Bhd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPHARMA's stock price target?
Price Target
1.72
MYR
1.72
MYR
According to Wall Street analysts, the average 1-year price target for DPHARMA is 1.72 MYR with a low forecast of 1.59 MYR and a high forecast of 1.88 MYR.
What is the Revenue forecast for Duopharma Biotech Bhd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Duopharma Biotech Bhd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Duopharma Biotech Bhd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Duopharma Biotech Bhd?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Duopharma Biotech Bhd?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 10%.